JOURNAL OF MEDICAL ECONOMICS

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study

Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma

Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma

A discrete-choice experiment to assess treatment modality preferences of patients with depression

Treatment patterns and predictors of costs among patients with migraine: evidence from the United States medical expenditure panel survey

Costs of administration, travelling, and productivity losses associated with hospital administration of multiple myeloma drugs in Finland

Cost-effectiveness of alemtuzumab and natalizumab for relapsing-remitting multiple sclerosis treatment in Iran: decision analysis based on an indirect comparison

Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma

Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective

Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants

Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK

Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study

Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK

The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes

Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis

Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong

Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand

Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm

Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders

Cost-effectiveness of sorafenib versus best supportive care in advanced hepatocellular carcinoma in Egypt

The economic burden of uncontrolled gout: how controlling gout reduces cost

Decrease in American birth rates makes it imperative for the United States to implement state mandated fertility coverage

Clinical characteristics, treatment pattern, and medical costs associated with metastatic castration-resistant prostate cancer in Chinese tertiary care hospital settings

The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom

Cost-effectiveness of rivaroxaban versus apixaban for the initial treatment of venous thromboembolism and extended prevention of recurrences in the UK

Current treatment patterns and medical costs for multiple myeloma in Japan: a cross-sectional analysis of a health insurance claims database

Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US

Federal government-interest patent disclosures for recent top-selling drugs

The real-world economic impact of home-based video electroencephalography: the payer perspective

A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial

Outcomes of transcatheter aortic valve implantation for intermediate-risk patients in Australia: the SOLACE-AU trial

Constructing a value-based healthcare system for hypertensive patients through changing payment mode: evidence from a comparative study in rural China

Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy

Fingolimod versus natalizumab in patients with relapsing remitting multiple sclerosis: a cost-effectiveness and cost-utility study in Iran

Healthcare costs and resource utilization in patients with severe aplastic anemia in the US

Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy

Number needed to treat and cost per remitter for biologic treatments of Crohn’s disease in Japan

Retrospective analysis of patients with advanced or metastatic gastric cancer in Colombia

Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective

Reply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain

Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models

Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation in the Japanese healthcare setting

Reoperations in intramedullary fixation of pertrochanteric hip fractures

A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt

Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France

Correction